Myalgia, hyper-CK-aemia, and hypocoagulability in a patient under rosuvastatin and warfarin.
Finsterer
J
J
Stöllberger
C
C
D000925:Anticoagulants / Q000627:therapeutic use*; D002797:Choline Kinase / Q000378:metabolism*; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy* / Q000378:metabolism; D011000:Pleurodynia, Epidemic / Q000188:drug therapy* / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D014859:Warfarin; D000068718:Rosuvastatin Calcium; D002797:Choline Kinase